- 全部删除
 您的购物车当前为空 您的购物车当前为空
Altiratinib (DCC-2701) 是一种多靶点激酶抑制剂,能够抑制 MET (IC50:2.7 nM),TIE2 (IC50:8 nM),VEGFR2 (IC50:9.2 nM),FLT3 (IC50:9.3 nM),Trk1 (IC50:0.85 nM),Trk2 (IC50:4.6 nM) 和 Trk3 (IC50:0.83 nM)。


为众多的药物研发团队赋能,
让新药发现更简单!
Altiratinib (DCC-2701) 是一种多靶点激酶抑制剂,能够抑制 MET (IC50:2.7 nM),TIE2 (IC50:8 nM),VEGFR2 (IC50:9.2 nM),FLT3 (IC50:9.3 nM),Trk1 (IC50:0.85 nM),Trk2 (IC50:4.6 nM) 和 Trk3 (IC50:0.83 nM)。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 176 | In stock | |
| 5 mg | ¥ 455 | In stock | |
| 10 mg | ¥ 747 | In stock | |
| 25 mg | ¥ 1,280 | In stock | |
| 50 mg | ¥ 1,980 | In stock | |
| 100 mg | ¥ 3,730 | In stock | |
| 500 mg | ¥ 7,880 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 513 | In stock | 
Altiratinib 相关产品
| 产品描述 | Altiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro. | 
| 靶点活性 |  Trk3:0.93 nM, TrkC:0.85 nM, VEGFR2:9.2 nM, MET (Y1230C):1.2 nM, MET (D1228N):1.3 nM, TrkA:0.85 nM, FLT3:9.3 nM, Trk2:4.6 nM, Tie2:8 nM, MET (Y1230C):0.37 nM | 
| 别名 | DCC-2701 | 
| 分子量 | 510.46 | 
| 分子式 | C26H21F3N4O4 | 
| CAS No. | 1345847-93-9 | 
| Smiles | Fc1ccc(NC(=O)C2(CC2)C(=O)Nc2cc(F)c(Oc3ccnc(NC(=O)C4CC4)c3)cc2F)cc1 | 
| 密度 | 1.557 g/cm3 (Predicted) | 
| 颜色 | White | 
| 物理性状 | Solid | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 45 mg/mL (88.16 mM), Sonication is recommended.   | ||||||||||||||||||||||||||||||
| 溶液配制表 | |||||||||||||||||||||||||||||||
| DMSO 
 | |||||||||||||||||||||||||||||||
 比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μL ,
比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μL ,  一共给药动物 10 只 ,您使用的配方为 5%
 一共给药动物 10 只 ,您使用的配方为 5%  DMSO+ 30%PEG300+ 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为 2 mg/mL 。
DMSO+ 30%PEG300+ 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为 2 mg/mL 。 
评论内容